| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | ms6648-12 | Grouping:Control | Gender:Female | nmol/vial |
| Reversed phase NEGATIVE ION MODE | ms6648-17 | Grouping:Control | Gender:Female | nmol/vial |
| Reversed phase NEGATIVE ION MODE | ms6648-22 | Grouping:Control | Gender:Female | nmol/vial |
| Reversed phase NEGATIVE ION MODE | ms6648-4 | Grouping:Control | Gender:Female | nmol/vial |
| Reversed phase NEGATIVE ION MODE | ms6648-5 | Grouping:Control | Gender:Female | nmol/vial |
| Reversed phase NEGATIVE ION MODE | ms6648-10 | Grouping:Control | Gender:Male | nmol/vial |
| Reversed phase NEGATIVE ION MODE | ms6648-20 | Grouping:Control | Gender:Male | nmol/vial |
| Reversed phase NEGATIVE ION MODE | ms6648-25 | Grouping:Control | Gender:Male | nmol/vial |
| Reversed phase NEGATIVE ION MODE | ms6648-6 | Grouping:Control | Gender:Male | nmol/vial |
| Reversed phase NEGATIVE ION MODE | ms6648-9 | Grouping:Control | Gender:Male | nmol/vial |
| Reversed phase NEGATIVE ION MODE | ms6648-15 | Grouping:Weight Losing | Gender:Female | nmol/vial |
| Reversed phase NEGATIVE ION MODE | ms6648-18 | Grouping:Weight Losing | Gender:Female | nmol/vial |
| Reversed phase NEGATIVE ION MODE | ms6648-19 | Grouping:Weight Losing | Gender:Female | nmol/vial |
| Reversed phase NEGATIVE ION MODE | ms6648-2 | Grouping:Weight Losing | Gender:Female | nmol/vial |
| Reversed phase NEGATIVE ION MODE | ms6648-28 | Grouping:Weight Losing | Gender:Female | nmol/vial |
| Reversed phase NEGATIVE ION MODE | ms6648-1 | Grouping:Weight Losing | Gender:Male | nmol/vial |
| Reversed phase NEGATIVE ION MODE | ms6648-14 | Grouping:Weight Losing | Gender:Male | nmol/vial |
| Reversed phase NEGATIVE ION MODE | ms6648-21 | Grouping:Weight Losing | Gender:Male | nmol/vial |
| Reversed phase NEGATIVE ION MODE | ms6648-24 | Grouping:Weight Losing | Gender:Male | nmol/vial |
| Reversed phase NEGATIVE ION MODE | ms6648-27 | Grouping:Weight Losing | Gender:Male | nmol/vial |
| Reversed phase NEGATIVE ION MODE | ms6648-13 | Grouping:Weight Stable | Gender:Female | nmol/vial |
| Reversed phase NEGATIVE ION MODE | ms6648-26 | Grouping:Weight Stable | Gender:Female | nmol/vial |
| Reversed phase NEGATIVE ION MODE | ms6648-29 | Grouping:Weight Stable | Gender:Female | nmol/vial |
| Reversed phase NEGATIVE ION MODE | ms6648-3 | Grouping:Weight Stable | Gender:Female | nmol/vial |
| Reversed phase NEGATIVE ION MODE | ms6648-8 | Grouping:Weight Stable | Gender:Female | nmol/vial |
| Reversed phase NEGATIVE ION MODE | ms6648-11 | Grouping:Weight Stable | Gender:Male | nmol/vial |
| Reversed phase NEGATIVE ION MODE | ms6648-16 | Grouping:Weight Stable | Gender:Male | nmol/vial |
| Reversed phase NEGATIVE ION MODE | ms6648-23 | Grouping:Weight Stable | Gender:Male | nmol/vial |
| Reversed phase NEGATIVE ION MODE | ms6648-30 | Grouping:Weight Stable | Gender:Male | nmol/vial |
| Reversed phase NEGATIVE ION MODE | ms6648-7 | Grouping:Weight Stable | Gender:Male | nmol/vial |
Return to study ST001010 main page
Download data matrix(NEFA Panel in Muscle Tissue of Muscle Wasting in Cancer Cachexia (part-V) Reversed phase NEGATIVE ION MODE)
- Metabolomics Workbench
|